buthionine sulfoximine has been researched along with Manganese Poisoning in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Filipov, NM; Lawrence, DA; Seegal, RF | 1 |
Daniels, CK; Dukhande, VV; Hugus, JJ; Lai, JC; Malthankar-Phatak, GH | 1 |
2 other study(ies) available for buthionine sulfoximine and Manganese Poisoning
Article | Year |
---|---|
Manganese potentiates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B-dependent mechanism.
Topics: Acetylcysteine; Animals; Buthionine Sulfoximine; Cells, Cultured; Chromans; Cytokines; Enzyme Inhibitors; Inflammation; L-Lactate Dehydrogenase; Lipopolysaccharides; Manganese Poisoning; Mice; Microglia; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Pentoxifylline; Phosphodiesterase Inhibitors; Serine Proteinase Inhibitors; Tosylphenylalanyl Chloromethyl Ketone | 2005 |
Manganese-induced neurotoxicity is differentially enhanced by glutathione depletion in astrocytoma and neuroblastoma cells.
Topics: Antimetabolites; Astrocytoma; Brain Neoplasms; Buthionine Sulfoximine; Cell Death; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Glutathione; Humans; Manganese Poisoning; Nerve Degeneration; Neuroblastoma | 2006 |